Cerclage plus progesterone versus progesterone alone for twins with a short cervix
Official title: Cervical Cerclage Plus Vaginal Progesterone Versus Vaginal Progesterone Alone in Twin Pregnancies With a Short Cervix for Prevention of Preterm Birth: a Randomized Controlled Trial
Run by National Hospital of Obstetrics and Gynecology · NCT07372495 · Data updated 2026-11-12
This will test whether adding a cervical stitch (cerclage) to progesterone helps prevent early birth in people carrying twins who have a short cervix (≤30 mm).
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 260 (estimated) |
| Sponsor | National Hospital of Obstetrics and Gynecology Academic / other |
| Locations | 6 sites (Bac Ninh and 5 other locations) |
| Status | Recruiting |
| Started | April 10, 2026 |
| Main results expected | December 30, 2028 |
| Study ends | May 30, 2029 |
| Registry record updated | April 24, 2026 |
| Trial ID | NCT07372495 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Pregnant people aged 18 or older with a twin pregnancy at 16+0 to 24+0 weeks and an ultrasound-confirmed cervical length ≤30 mm, without major fetal anomalies or signs of active labor, are ideal candidates.
✕Probably not a fit
People with monochorionic monoamniotic twins, twin-to-twin transfusion syndrome, cervical dilation, active preterm labor, prior indications for cerclage, or major fetal anomalies are excluded and unlikely to benefit from this approach.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Women with twin pregnancies between 16+0 and 24+0 weeks and a transvaginal cervical length of 30 mm or less are randomly assigned to receive either a cervical cerclage plus progesterone or progesterone alone. The trial compares rates of preterm birth and related neonatal outcomes between the two groups. Participants are screened to exclude those with major fetal anomalies, monochorionic monoamniotic gestations, twin-to-twin transfusion syndrome, cervical dilation, or active preterm labor. Follow-up includes obstetric monitoring through delivery and assessment of neonatal morbidity and mortality.
Why it matters
Potential benefit: If successful, adding cerclage to progesterone could reduce preterm births in twin pregnancies with a short cervix and lower neonatal complications and NICU stays.
How similar studies have gone: Previous studies of cerclage or progesterone alone in twin pregnancies have produced mixed or limited results, so the combined approach remains relatively untested and evidence is inconclusive.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Maternal age ≥ 18 * Twin pregnancy * Asymptomatic short cervix (CL≤30mm) at routine ultrasound investigation * Gestational age at 16+0- 24+0 weeks Exclusion Criteria: A potential paticipant who meets any of the following criteria will be excluded from participation in this trial: * Women with twin pregnancy in which one or both fetuses are diagnosed with a major structural or congenital abnormality that is likely to influence the composite adverse neonatal outcome. * Women with a monochorionic monoamniotic twin pregnancy * A monochorionic twin pregnancy with twin-to-twin transfusion syndrome before or at the time of inclusion. * Patients have indications for vaginal cerclage: Recurrent late miscarriage (from 14 weeks) or preterm birth occurring two or more times. * Women with dilatation of the cervix diagnosed by ultrasound or physical exam * Women with overt symptoms of preterm labor at the time of measurement of the short cervix (regular contractions, PPROM, recurrent blood loss). * Women with the presence of fever ≥ 38 degrees Celsius. * Women with a placenta previa, vasa previa. * Uterine malformations: unicornuate uterus, bicornuate uterus, uterine septum, fibroid… * Severe maternal conditions (heart failure, chronic kidney disease, systemic lupus erythematosus …)
Where it's running
-
National Hospital of Obstetrics and Gynecology
Hanoi, Vietnam Recruiting -
Bac Ninh 1 Obstetrics and Pediatrics Hospital, Bac Ninh, Vietnam
Bac Ninh, Vietnam Not yet recruiting -
Bac Ninh 2 Obstetrics and Pediatrics Hospital, Bac Ninh, Vietnam
Bac Ninh, Vietnam Not yet recruiting -
Hung Yen Obstetrics and Pediatrics Hospital, Hung Yen, Vietnam
Hung Yen, Vietnam Not yet recruiting -
Ninh Binh Obstetrics and Pediatrics Hospital, Ninh Binh, Vietnam
Ninh Bình, Vietnam Not yet recruiting -
Quang Ninh Obstetrics and Pediatrics Hospital, Quang Ninh, Vietnam
Quang Ninh, Vietnam Not yet recruiting
Study contacts
- Study coordinator: Thu Ha T Nguyen, Assoc. Prof
- Email: dr.hanguyen.nhog@gmail.com
- Phone: 84965995599
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Premature infants: trying PIOMI with mom to support feeding
Aims to see if PIOMI done with a mother’s presence and voice helps preterm babies feed better and feel more connected to mom.
-
SAFE early intervention for high-risk infants to support arm function
This randomized trial tests whether the SAFE early intervention helps improve upper limb function and early development in high-risk infants aged 3–12 months compared with standard Neurodevelopmental Treatment (NDT).
-
PIMUN to reduce low-oxygen episodes in preterm infants
We will test whether PIMUN, a soft garment that gives gentle pulsatile dorsal stimulation, can reduce low-oxygen (SpO2 <90%) episodes in preterm infants born at 24–34 weeks who have apnea of prematurity.
-
Helping preterm babies learn to feed using scheduled pacifier use
This study tests whether giving preterm babies a 5-minute pacifier before each feeding versus a 30-minute pacifier at random times helps them develop feeding skills faster and leave the hospital sooner.
-
Early physiotherapy to improve motor optimality in at-risk infants
This trial will test whether starting a targeted physiotherapy program early improves motor movement scores in infants born preterm or who had serious neonatal complications.
-
Household, wellbeing, and quality-of-life impacts of very preterm birth and necrotising enterocolitis
This project will collect information to see if pausing or continuing milk feeds around blood transfusions relates to babies' quality of life and the financial and emotional impact on families of very preterm infants, especially those with NEC.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.